Literature DB >> 230287

Pathogenesis of murine cytomegalovirus infection: the macrophage as a permissive cell for cytomegalovirus infection, replication and latency.

A R Brautigam, F J Dutko, L B Olding, M B Oldstone.   

Abstract

Macrophages harvested from the peritoneal cavities of mice of several strains were permissive to infection with murine cytomegalovirus (MCMV). Macrophages from six mouse strains released equivalent amounts of plaque-forming virus into the culture fluids and cells from mouse strains scored similarly in numbers of infectious centres. Twenty to 50% of the infected macrophages obtained after thioglycollate activation formed infectious centres. When studied by in situ hybridization, more than 82% of infected macrophages (with or without thioglycollate activation) contained MCMV DNA. Macrophages obtained from latently infected mice were examined for their content of MCMV. Using co-cultivation assays, MCMV was frequently recovered from thioglycollate activated macrophages harvested from latently infected mice but only rarely recovered from non-activated macrophages. MCMV DNA--mouse DNA hybridization assays revealed four to seven virus genome DNA copies per 100 cells. These studies indicate that macrophages harvested from mice susceptible (BALB/cSt) or resistant (C3H) to MCMV infection replicated virus equivalently and that macrophages are a reservoir of MCMV during latent and chronic infections. Activation of macrophages may be one of the important steps leading to the exacerbation of in vivo latent infections.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 230287     DOI: 10.1099/0022-1317-44-2-349

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  59 in total

1.  Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs.

Authors:  N K Grzimek; D Dreis; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Characterization of a murine cytomegalovirus-induced immunosuppressive factor.

Authors:  P F Whyte; R Subramaniam; J B Hudson
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

Authors:  J A Mercer; C A Wiley; D H Spector
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

4.  Focal transcriptional activity of murine cytomegalovirus during latency in the lungs.

Authors:  S K Kurz; M Rapp; H P Steffens; N K Grzimek; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 5.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

6.  DMSO induces reactivation of cytomegalovirus in vitro from spleens of latently infected mice. Brief report.

Authors:  S Blackett; A Gupta; C A Mims
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

7.  Herpes Simplex Virus 1 Interaction with Myeloid Cells In Vivo.

Authors:  Maitreyi Shivkumar; Clara Lawler; Ricardo Milho; Philip G Stevenson
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

8.  The isolation and partial characterisation of a cytomegalovirus from the brown rat, Rattus norvegicus.

Authors:  P K Priscott; D A Tyrrell
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  Productive infection of isolated human alveolar macrophages by respiratory syncytial virus.

Authors:  J R Panuska; N M Cirino; F Midulla; J E Despot; E R McFadden; Y T Huang
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

10.  Enhancement of dengue virus type 2 replication in mouse macrophage cultures by bacterial cell walls, peptidoglycans, and a polymer of peptidoglycan subunits.

Authors:  H Hotta; S Hotta; H Takada; S Kotani; S Tanaka; M Ohki
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.